BioSpecifics Technologies Corp. (BSTC) Jumps 5.27% on February 10

Equities Staff |

BioSpecifics Technologies Corp. (BSTC) was among the biggest gainers on the Russell 2000 for Wednesday February 10 as the stock popped 5.27% to $32.97, representing a gain of $1.65 per share. Some 51,497 shares traded hands on 427 trades, compared with an average daily volume of 70,105 shares out of a total float of 6.92 million. The stock opened at $32.02 and traded with an intraday range of $34.06 to $30.70.

After today's gains, BioSpecifics Technologies Corp. reached a market cap of $228.09 million. BioSpecifics Technologies Corp. has had a trading range between $72.07 and $30.81 over the last year, and it had a 50-day SMA of $40.94 and a 200-day SMA of $48.34.

The stock has a P/E Ratio of 25.7.

BioSpecifics Technologies Corp is a biopharmaceutical company, which is engaged in the development of an injectable collagenase for multiple indications.

BioSpecifics Technologies Corp. is based out of Lynbrook, NY and has some 5 employees. Its CEO is Thomas L. Wegman.

For a complete fundamental analysis analysis of BioSpecifics Technologies Corp., check out’s Stock Valuation Analysis report for BSTC. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Kiwa Bio-Tech Products Group Corp

Kiwa Bio-Tech Products Group Corp develops, manufactures, distributes and markets, cost-effective and environmentally safe bio-technological products for agriculture in China.

Private Markets


Airbnb is a community marketplace for people to list, discover, and book unique accommodations around the world — online or from a mobile phone. Whether an apartment for a night,…


Autonomous security robots providing advanced detection capabilities at $7 per hour - aiming to define the future of security. Help #StopTheViolence.